Novartis, Roxane Drop Most Famvir Patent Claims
A federal judge has approved a joint move by Novartis Pharmaceuticals Corp. and Roxane Laboratories Inc. to dismiss claims regarding three of four patents in the drugmakers' battle over Novartis herpes...To view the full article, register now.
Already a subscriber? Click here to view full article